Follow NWC SCN and Senate on Twitter

Achievements 2015-16

Key achievements : What we did in 2015 - 2016

  • Continued to support clinical engagement at primary, secondary and tertiary care level through tumour specific clinical network groups.  This provided clinical leadership and ownership to the service improvement initiatives.
  • Facilitated a consistent approach to assure cancer services with a standard policy on undertaking cancer peer review which resulted in network-wide agreed diagnostic and treatment guidelines remained compliant with peer review quality standards.
  • Supported Acute Hospital Trusts in assessing and validating cancer services through their internal quality assurance framework, thereby ensuring that all clinical teams were assessed against a robust validation and quality assurance process.
  • Facilitated wider network engagement through Primary Care and Acute Trust cancer managers to review and understand breaches against cancer waiting time standards.  This ensured that network cancer waiting times performance for 62 days remained consistently above the operational standard of 85%.
  • Facilitated a network agreed specification for video-conferencing in line with recommendations of NCAT guidance on effective MDT working.  This enabled Acute Trusts to procure fit-for-purpose video-conferencing equipment.
  • Working in partnership with Macmillan to support the cancer recovery package consistently across the network allowed Acute Trusts to measure holistic needs assessment and end of treatment summaries on a quarterly basis, in order to increase the percentage number of completed records.  Agreement was also reached for a commissioning for quality and innovation (CQUIN) payment to be introduced in 2016/17.
  • Facilitated the development of revised two week wait referral forms and education materials following publication of the NICE Guidelines on Suspected Cancer 2015.
  • Supported patient and carer engagement in cancer services through representation on cancer clinical network groups in line with cancer peer review.